title: Autoimmunity by anti-tumour necrosis factor-alpha agents: the role of traditional therapies.
authors.forename: C
authors.initials: C
authors.lastname: Antoniou
authors.forename: A E
authors.initials: AE
authors.lastname: Moustou
authors.forename: T
authors.initials: T
authors.lastname: Vergou
authors.forename: A
authors.initials: A
authors.lastname: Stratigos
authors.forename: A
authors.initials: A
authors.lastname: Kalambokas
authors.forename: A D
authors.initials: AD
authors.lastname: Katsambas
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis / Q000276:immunology*; D015551:Autoimmunity / Q000187:drug effects*; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D011565:Psoriasis / Q000188:drug therapy / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab